Dear Ms. Tilyou,
I am writing you regarding a recent Gastroenterology & Endoscopy News article (2024;75[1]:7). The article, titled “Nasal Metoclopramide Reduces Costs for Patients With Diabetic Gastroparesis” and authored by Chase Doyle, was an excellent synopsis of an important advancement in the treatment of diabetic gastroparesis and, most notably, how nasal metoclopramide can reduce costs for patients and payors compared with oral metoclopramide. However, the last paragraph